Doseloop Beta

Nattokinase

supplement Under review

A fibrinolytic enzyme extracted from the traditional Japanese food natto, often used to support cardiovascular health.

Research May Be Outdated

This habit has been flagged for a research update. Recent studies may not be included.

Research summary

AI-Generated Content: This summary was created by AI and may contain errors. Always verify with peer-reviewed sources.

Scientific evidence from human studies, primarily randomized controlled trials and meta-analyses, indicates that nattokinase supplementation can modestly reduce systolic and diastolic blood pressure in healthy adults and those with elevated levels. Higher doses around 10,800 FU daily appear more effective for reducing arterial plaque size, triglycerides, and LDL cholesterol compared to lower doses, with benefits more pronounced in certain subgroups like obese or active individuals. While fibrinolytic and antithrombotic effects are supported, lipid improvements are inconsistent at lower doses, and overall evidence is promising but limited by small study numbers and calls for larger trials.

Reported Benefits

No side effects tracked yet

No side effects have been reported by studies or users for this habit yet.

Related health conditions

Research showing how this habit affects specific health conditions. Always consult healthcare professionals.

May Help With

Research (4 studies)

Meta-Analysis

Nattokinase Supplementation and Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Nutrition, Metabolism and Cardiovascular Diseases • 2024 • n=546

Chen H, McGowan EM, Ren N, et al.

RCT

Nattokinase and Red Yeast Rice Combination for Cardiovascular Health: A Randomized, Double-Blinded, Placebo-Controlled Trial

Frontiers in Nutrition • 2024 • n=120

Chen WT, et al.

RCT

Nattokinase Prevents the Progression of Atherosclerosis by Reducing Arterial Plaque Size: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Frontiers in Cardiovascular Medicine • 2022 • n=1062

Ren NN, Chen H, Li Y, McGowan E, Lin Y

Systematic Review

Nattokinase: A Promising Alternative in Prevention and Treatment of Cardiovascular Diseases.

Biomarker Insights • 2017

Weng Y, Yao J, Sparks S, Wang KY

Discovered by @matt

Community updates

No updates yet for this supplement.

Be the first to share your experience!

At a glance

Users tracking 0
Linked studies 4
Researched benefits 3
Side effects noted 0